Literature DB >> 23603418

Reconstruction of the evolutionary dynamics of hepatitis C virus subtypes in Montenegro and the Balkan region.

Gianguglielmo Zehender1, Chiara Sorrentino, Alessia Lai, Erika Ebranati, Elena Gabanelli, Alessandra Lo Presti, Danijela Vujoševic, Dragan Lauševic, Dragica Terzić, Renata Shkjezi, Silvia Bino, Zoran Vratnica, Boban Mugosa, Massimo Galli, Massimo Ciccozzi.   

Abstract

More than 20 million hepatitis C virus (HCV) carriers live in the countries of the Eastern Mediterranean. We determined HCV genotype distribution among chronically infected patients in Montenegro and investigated the phylodynamics and phylogeography of the most represented HCV subtypes. The HCV-NS5b sequences of the Montenegrin patients were compared with sequences isolated in different known localities of the Mediterranean area, Europe and Asia. A Bayesian approach was used in order to allow the simultaneous estimate of the evolutionary rate, time-scaled phylogeny, demography and ancestral spatial status. The most frequent HCV subtypes among the Montenegrin patients, were 1b (34.7%) and 3a (24.7%), but there was also a significant prevalence of 1a and 4d (19.5%). Subtype 3a was significantly more frequent among younger patients and intravenous drug users (IDUs), whereas subtype 1b was more frequently associated with iatrogenic exposure and older ages. The spatio-temporal analysis of the epidemic suggested that HCV-1b penetrated Europe at the beginning of the XX century, probably through Greece and Cyprus and in the 1920s reached Montenegro, where there was an exponential increase in the effective number of infections between the 1950s and 1970s. The phylogeographic and phylodynamic analysis of HCV 3a showed that its most probable origin was in the Indian sub-continent (Pakistan in our reconstruction) about 300years ago. The evolutionary dynamics analysis showed that HCV-3a reached Montenegro more recently in the late 1970s and underwent multi-phasic growth still persisting. Our data suggest multiple introduction of HCV subtypes in the area, supported by different causes of dispersion: adverse social conditions and unsafe medical practices for HCV-1b and i.v. drug use for HCV-3a.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23603418     DOI: 10.1016/j.meegid.2013.04.003

Source DB:  PubMed          Journal:  Infect Genet Evol        ISSN: 1567-1348            Impact factor:   3.342


  10 in total

Review 1.  Injecting drug use: A vector for the introduction of new hepatitis C virus genotypes.

Authors:  Simona Ruta; Costin Cernescu
Journal:  World J Gastroenterol       Date:  2015-10-14       Impact factor: 5.742

Review 2.  Enigmatic origin of hepatitis B virus: an ancient travelling companion or a recent encounter?

Authors:  Gianguglielmo Zehender; Erika Ebranati; Elena Gabanelli; Chiara Sorrentino; Alessandra Lo Presti; Elisabetta Tanzi; Massimo Ciccozzi; Massimo Galli
Journal:  World J Gastroenterol       Date:  2014-06-28       Impact factor: 5.742

3.  Analysis of the ORFK1 hypervariable regions reveal distinct HHV-8 clustering in Kaposi's sarcoma and non-Kaposi's cases.

Authors:  Paola Cordiali-Fei; Elisabetta Trento; Marta Giovanetti; Alessandra Lo Presti; Alessandra Latini; Massimo Giuliani; Giovanna D'Agosto; Valentina Bordignon; Eleonora Cella; Francesca Farchi; Carmela Ferraro; Ilaria Lesnoni La Parola; Carlo Cota; Isabella Sperduti; Antonella Vento; Antonio Cristaudo; Massimo Ciccozzi; Fabrizio Ensoli
Journal:  J Exp Clin Cancer Res       Date:  2015-01-16

4.  The Phylogeographic and Spatiotemporal Spread of HCV in Pakistani Population.

Authors:  Noor-Ul-Huda Ghori; Atif Shafique; Muhammad Qasim Hayat; Sadia Anjum
Journal:  PLoS One       Date:  2016-10-20       Impact factor: 3.240

5.  A very high prevalence of hepatitis C virus infection among patients undergoing hemodialysis in Kosovo: a nationwide study.

Authors:  Xhevat Jakupi; Jana Mlakar; Maja M Lunar; Katja Seme; Ibrahim Rudhani; Lul Raka; Adriana Vince; Mario Poljak
Journal:  BMC Nephrol       Date:  2018-11-03       Impact factor: 2.388

6.  HCV transmission in high-risk communities in Bulgaria.

Authors:  Lilia Ganova-Raeva; Zoya Dimitrova; Ivailo Alexiev; Lili Punkova; Amanda Sue; Guo-Liang Xia; Anna Gancheva; Reneta Dimitrova; Asya Kostadinova; Elitsa Golkocheva-Markova; Yury Khudyakov
Journal:  PLoS One       Date:  2019-03-05       Impact factor: 3.240

7.  Prevalence of Hepatitis C virus genotypes in nine selected European countries: A systematic review.

Authors:  Arnolfo Petruzziello; Giovanna Loquercio; Rocco Sabatino; Daniel Vasile Balaban; Najeeb Ullah Khan; Mauro Piccirillo; Luis Rodrigo; Lucia di Capua; Annunziata Guzzo; Francesco Labonia; Gerardo Botti
Journal:  J Clin Lab Anal       Date:  2019-03-07       Impact factor: 2.352

8.  Molecular Epidemiology and Baseline Resistance of Hepatitis C Virus to Direct Acting Antivirals in Croatia.

Authors:  Petra Simicic; Anamarija Slovic; Leona Radmanic; Adriana Vince; Snjezana Zidovec Lepej
Journal:  Pathogens       Date:  2022-07-19

9.  The Transmission Route and Selection Pressure in HCV Subtype 3a and 3b Chinese Infections: Evolutionary Kinetics and Selective Force Analysis.

Authors:  Ru Xu; Xia Rong; Elihu Aranday-Cortes; Sreenu Vattipally; Joseph Hughes; John McLauchlan; Yongshui Fu
Journal:  Viruses       Date:  2022-07-11       Impact factor: 5.818

10.  Spatiotemporal Reconstruction of the Introduction of Hepatitis C Virus into Scotland and Its Subsequent Regional Transmission.

Authors:  Anna L McNaughton; Iain Dugald Cameron; Elizabeth B Wignall-Fleming; Roman Biek; John McLauchlan; Rory N Gunson; Kate Templeton; Harriet Mei-Lin Tan; E Carol McWilliam Leitch
Journal:  J Virol       Date:  2015-08-26       Impact factor: 5.103

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.